TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is a non-invasive alternative to surgery to control primary renal cell cancer (RCC) in patients that are medically inoperable or at high-risk of post-surgical dialysis. The objective of the FASTRACK II clinical trial is to investigate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Siva, Shankar, Chesson, Brent, Bressel, Mathias, Pryor, David, Higgs, Braden, Reynolds, Hayley M., Hardcastle, Nicholas, Montgomery, Rebecca, Vanneste, Ben, Khoo, Vincent, Ruben, Jeremy, Lau, Eddie, Hofman, Michael S., De Abreu Lourenco, Richard, Sridharan, Swetha, Brook, Nicholas R., Martin, Jarad, Lawrentschuk, Nathan, Kron, Tomas, Foroudi, Farshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199711/
https://www.ncbi.nlm.nih.gov/pubmed/30352550
http://dx.doi.org/10.1186/s12885-018-4916-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199711/
https://www.ncbi.nlm.nih.gov/pubmed/30352550
http://dx.doi.org/10.1186/s12885-018-4916-2

Ejemplares similares